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Summary
Background Mass deworming against soil-transmitted helminthiasis, which affects 1 billion of the poorest people 
globally, is one of the largest public health programmes for neglected tropical diseases, and is intended to be equitable. 
However, the extent to which treatment programmes for deworming achieve equitable coverage across wealth class 
and sex is unclear and the public health metric of national deworming coverage does not include representation of 
equity. This study aims to measure both coverage and equity in global, national, and subnational deworming to guide 
future programmatic evaluation, investment, and metric design.
Methods We used nationally representative, geospatial, household data from Demographic and Health Surveys that 
measured mother-reported deworming in children of preschool age (12–59 months). Deworming was defined as 
children having received drugs for intestinal parasites in the previous 6 months before the survey. We estimated 
deworming coverage disaggregated by geography, wealth quintile, and sex, and computed an equity index. We 
examined trends in coverage and equity index across countries, within countries, and over time. We used a regression 
model to compute the household correlates of deworming and ecological correlates of equitable deworming.
Findings Our study included 820 883 children living in 50 countries from Africa, the Americas, Asia, and Europe that 
are endemic for soil-transmitted helminthiasis using 77 Demographic and Health Surveys from December, 2003, to 
October, 2017. In these countries, the mean deworming coverage in preschool children was estimated at 33·0% (95% CI 
32·9–33·1). The subnational coverage ranged from 0·5% to 87·5%, and within-country variation was greater than 
between-country variation. Of the 31 countries reporting that they reached the WHO goal of more than 75% national 
coverage, 30 had inequity in deworming, with treatment concentrated in wealthier populations. We did not detect 
systematic differences in deworming equity by sex.
Interpretation Substantial inequities in mass deworming programmes are common as wealthier populations have 
consistently higher coverage than that of the poor, including in countries reporting to have reached the WHO goal of 
more than 75% national coverage. These inequities seem to be geographically heterogeneous, modestly improving 
over time, with no evidence of sex differences in inequity. Future reporting of deworming coverage should consider 
disaggregation by geography, wealth, and sex with incorporation of an equity index to complement the conventional 
public health metric of national deworming coverage.
Funding Bill & Melinda Gates Foundation, Stanford University Medical Scientist Training Program.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 
license.
Introduction
Soil-transmitted helminthiasis is the most prevalent 
neglected tropical disease affecting up to 1 billion people.1–3 
Soil-transmitted helminthiasis affects the most dis ad-
vantaged people, helps to drive the cycle of poverty, 
and contributes to health inequities.4,5 Soil-transmitted 
helminthiasis is defined as infection with one or more 
helminths from Ascaris lumbricoides (roundworm), 
Ancylostoma duodenale and Necator americanus (hook-
worm), and Trichuris trichiura (whipworm), and is 
associated with a range of sequelae from present or past 
infection, including chronic abdominal pain, anaemia, 
micronutrient deficiency, and stunting.6–9 The global public 
health strategy against soil-transmitted helminthi asis is 
WHO-recommended deworming, often through 
preventive chemotherapy or mass drug administration, 
which is the widespread empirical treatment of at-risk 
populations at routine intervals. For soil-transmitted 
helminthiasis, deworming programmes focus on school-
age (ages 5–14 years) and preschool age (ages 1–4 years) 
children.10,11 Deworming programmes treat almost 
600 million children annually, which makes them one of 
the largest public health programmes in the world.10,12
Although soil-transmitted helminthiasis affects the 
most economically and socially disadvantaged, the degree 
to which deworming treatment programmes reach people 
most in need is unclear. Equitable deworming would 
include all individuals at risk with coverage that is 
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generally proportional to the level of risk of soil-trans mitted 
helminthiasis.2,13,14 Deworming is often considered a so-
called pro-poor public health effort because the risk of 
soil-transmitted helminthiasis is likely to be higher 
in populations that are poorer, have lower educational 
status, and live in settings with inadequate sanita tion.2,11,13–16 
This consideration would suggest that deworming, if 
equitable, would then trend towards having higher 
coverage in poorer populations.2,11,13–16 The prevalence of 
soil-transmitted helminthiasis would likely be equal by 
sex given limited biological plausibility for differential risk 
of infection, therefore equitable deworming would be 
expected to have equal coverage by sex.14,15
Historically, national deworming coverage reported to 
WHO has been used to track progress of country 
programmes as the conventional metric, which follows 
the WHO public health goal of achieving 75% national 
coverage or greater.5 However, national deworming 
coverage does not necessarily reflect equity by economic 
status, sex, or geography. Specifically, national deworming 
coverage might be subject to a so-called tyranny of 
averages: the average coverage might appear higher 
despite low coverage in large geographical regions,17 
economically disadvantaged populations, or other key 
subgroups. As a result, overall understanding of cor relates 
of deworming that might be related to equity is not clear.
The goal of equity lies at the foundation of global health, 
although the emphasis on measuring and tracking equity 
in public health programmes has only increased with 
the Sustainable Development Goals.18 Literature exists, 
particularly for child mortality, on metrics to estimate 
equity for various public health programmes using sum-
mary statistics (eg, ratios) and indices (eg, concentration 
index).19,20 Yet, application of these metrics to routine 
measurement, tracking progress over time, or setting 
public health targets remains limited. However, in 2016, 
WHO provided guidance on equity metrics, recom-
mending disaggregating programmatic data by geography, 
wealth, and sex.20
Mass deworming has been promoted as an example of 
an equitable intervention in global health, yet the extent 
to which this assumption is true remains unclear given 
limited monitoring of equity with disaggregation of data 
or incorporation of equity measures. The aim of this 
study was to estimate the global status and trends in 
national and subnational deworming coverage and equity 
by wealth and sex to test the degree to which deworming 
for soil-transmitted helminthiasis is equitable.
Research in context
Evidence before this study
We searched PubMed for relevant articles published in English 
from database conception to April 11, 2019, using the search 
terms “soil-transmitted helminth” or “deworm” or “intestinal” 
together with “equity” restricted to the title and abstract fields. 
This search identified 11 articles. None of these studies assessed 
the equity of deworming programmes on a subnational level or 
stratified by wealth and sex. We did identify an article 
constructing a country level, multiple neglected tropical disease 
index, which was computed using national coverage of multiple 
programmes of these diseases. We also found a multicountry 
study that found general equity by sex of the coverage of these 
programmes.
Added value of this study
This study provides a multicountry analysis on the state and 
trends in coverage and equity of deworming programmes using 
subnational, maternal-reported data from 820 883 preschool 
age children in 50 countries, which could be incorporated into 
routine evaluation of deworming programmes. We find that 
although deworming is often considered an equitable public 
health intervention meaning poorer populations have higher 
coverage, deworming coverage and equity is highly variable 
and medicines are generally not reaching the poor equitably 
(ie, wealthier populations are more likely to be treated). This 
variability is despite often high national coverage reported to 
WHO. Over time, deworming coverage by wealth seems to be 
modestly becoming more equal with reductions in within 
country variation in equity index. We found no evidence of 
sex-related differences in deworming equity. This study goes 
beyond previous work to provide a rigorous comprehensive 
evaluation of the coverage and equity of deworming 
programmes at a subnational level with disaggregation by 
wealth and sex using person-level household data and provides 
actionable information that can strengthen future 
measurement and evaluation of national deworming 
programmes.
Implications of all the available evidence
Deworming programmes are one of the largest public health 
programmes globally, and the public health metric used to track 
progress is national deworming coverage, which might 
preclude sensitive measurement of inequity. Our study findings 
support the opportunity for reporting of deworming coverage 
on a subnational level that is disaggregated by wealth and sex 
with opportunity to incorporate an equity index to 
complement routinely reported national deworming coverage. 
The measurement of equity in deworming programmes can be 
readily addressed through use of secondary datasets such as the 
Demographic and Health Surveys. To fully realise the potential 
of programmatic equity measures, the collaborative support of 
WHO, Ministries of Health, and non-governmental 
organisations will be necessary along with consideration of 
other public health needs in the country. Formal inclusion of 
subnational coverage data and an equity index will likely 
improve the ability of deworming programmes to address the 
disease burden of soil-transmitted helminthiasis affecting 
1 billion of the world’s poorest people.
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Methods
Data and study measures
We used the Demographic and Health Surveys to examine 
global, national, and subnational coverage and equity in 
deworming, and the associated correlates of deworming. 
Demographic and Health Survey data are nationally 
representative cross-sectional surveys on demographic, 
health, and health system indicators that are done in over 
90 low-income and middle-income countries approxi-
mately every 5 years.21 The Demographic and Health 
Surveys are funded by the US Agency for International 
Development, and independently imple mented by ICF 
International to ensure consistency in data quality over 
time. We analysed all available Demographic and Health 
Surveys that included data for deworming in preschool-
age children (1–4 years; 12–59 months). We excluded data 
at the national and subnational level in which deworming 
was not recommended because of low soil-transmitted 
helminthiasis prevalence or being non-endemic; sub-
national exclusion was on the basis of the geographical 
unit (ie, Demographic and Health Surveys region; 
administrative level one; appendix pp 3, 4). Estimates of 
drug coverage and equity were based on the most recent 
Demographic and Health Surveys for each country. For 
analyses related to temporal trends or correlates of 
deworming, we included all surveys when multiple 
Demographic and Health Surveys were available for a 
country. This study relied on previously collected 
microdata that were not individually identifiable and did 
not require human research approval.
The key outcome variable was deworming based on the 
mother’s report of whether her children had received 
drugs for intestinal parasites in the past 6 months before 
the survey. When multiple children lived in the 
household, the mother answered separately for each 
child. We estimated coverage disaggregated by wealth 
quintile (a composite index of household assets, stan-
dardised to each survey, and computed by Demographic 
and Health Surveys), sex, and geography.22 We used 
Demographic and Health Survey data for prespecified 
variables based on a statistical plan to measure the 
correlates of deworming, which included: child’s age and 
sex, mother’s age (<30 years or older), mother’s education 
(defined as no education, some primary school, or 
completion of primary school or higher education), 
wealth quintile, urban or rural residence (based on 
country definition, based on population or infrastructure 
definitions), access to improved drinking water source 
and to improved sanitation facility or toilets (two separate 
binary designations based on definitions used by the 
UNICEF/WHO Joint Monitoring Program23), and receipt 
of the third dose of the diphtheria, tetanus, and pertussis 
vaccine (DTP3) and vitamin A as generic markers of 
health-care access.7,24 We excluded observations with 
missing data for covariates, which was an estimated 
12% of the sample size (appendix pp 5, 12).
Statistical analysis of coverage and equity
We computed deworming coverage and equity at a 
subnational level across and within countries and over 
See Online for appendix
Dewormed 
(n=227 676)
Not dewormed 
(n=400 813)
Age (years) 2·8 2·3
Female sex 47·9% 48·6% 
Male sex 52·1% 51·4% 
Wealth quintile* 3·3 3·0
Children with mother’s age of more 
than 30 years
60·0% 63·2% 
Rural 66·9% 71·8% 
Mother’s education
No education 24·9% 34·1%
Some primary school education 22·4% 22·2%
Completion of primary school or 
higher education
52·7% 43·7%
Improved drinking water source 73·1% 70·1% 
Improved sanitation facility or toilet 55·2% 48·3% 
Receipt of 3rd dose of DPT vaccine 
(% received)
80·1% 61·2%
Receipt of vitamin A in past 6 months 81·1% 45·7%
Data are n or %. DTP=diphtheria, tetanus, and pertussis. *Wealth quintiles are 
ordinal variables: 1, 2, 3, 4, 5.
Table 1: Characteristics of the study population of preschool children
Panel: Study countries and data from Demographic and Health Surveys by country 
classification based on WHO regional offices
Africa region
Benin (2012); Burkina Faso (2010); Burundi (2010, 2016); Cameroon (2011); Chad (2014); 
Comoros (2012); Côte d’Ivoire (2012); Democratic Republic of the Congo (2007, 2013); 
Ethiopia (2010, 2016); Gabon (2012); Gambia (2013); Ghana (2008, 2014); 
Guinea (2012); Kenya (2008, 2014); Lesotho (2009, 2014); Liberia (2007, 2013); 
Madagascar (2008); Malawi (2010, 2015); Mali (2012); Mozambique (2011); 
Namibia (2006, 2013); Niger (2012); Nigeria (2008, 2013); Republic of the Congo (2011); 
Rwanda (2008, 2010, 2014); São Tomé and Príncipe (2008); Senegal (2010); 
Sierra Leone (2013); South Africa (2016); eSwatini, previously known as 
Swaziland (2006); Tanzania (2010, 2015); Togo (2013); Uganda (2006, 2011, 2016); 
Zambia (2007, 2013); Zimbabwe (2010, 2015)
Region of the Americas
Dominican Republic (2007, 2013); Guyana (2009); Haiti (2006, 2012, 2016); 
Honduras (2011); Peru (2004)
South-East Asia region
Bangladesh (2011, 2014); India (2015); Myanmar (2015); Nepal (2006, 2011, 2016); 
Timor-Leste (2009, 2016)
European region
Azerbaijan (2006)
Eastern Mediterranean region
Pakistan (2012); Yemen (2013)
Western Pacific region
Cambodia (2005, 2010, 2014); Philippines (2008, 2017)
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time. We computed a measure of equity in deworming 
by wealth using an equity index, which was estimated 
using a prespecified concentration index. The 
concentration index is a scalar measure of equality when 
considering a binary outcome (eg, deworming) over a 
range of another socio economic variable (eg, composite 
wealth score).25 The generalised calculation involves the 
summation of binary deworming weighted by wealth 
quintile (nor malised to zero) over the population with 
adjustment for overall deworming coverage and 
population size.25 We used the Erreygers correction, 
which provided technical advantages over other 
concentration indices, including satisfying a mirror 
condition (ie, inverse coding of the binary deworming 
variable would not affect the index).25 For interpretation, 
an equity index of 0 indicated that de worming was 
generally equally distributed across all five wealth classes. 
A negative equity index (bounded to a minimum of –1) 
indicated that deworming was con centrated in children 
from wealthier families; the closer to –1, the greater the 
concentration of deworming in children from wealthier 
families. A positive equity index (bounded to a maximum 
of 1) indicated that deworming was concentrated in 
children from poorer families; the closer to 1, the greater 
the concentration of deworming in children from poorer 
families. We estimated the proportion of variance in 
equity index, explained by within country compared with 
between country variation based on a previous approach 
with bootstrapped confidence inter vals,26 to understand 
whether inequity was driven more by national policy or 
within country differences (appendix p 5). Methodological 
details on further analyses to investigate equity trends 
are available in the appendix pp 5, 6.
Statistical analysis of correlates of deworming and equity
We computed the household-level correlates of de-
worming using all available survey data, including 
multiple surveys for a given country. The analysis used a 
Figure 1: Maternal-reported deworming coverage and equity in pre-school children in low- and middle-income countries
We estimated subnational deworming coverage (A, B, C) and the equity index (D, E, F) for all study countries. The map was geographically divided into the Americas (A, D), Africa (B, E), 
and South East Asia, Eastern Mediterranean, and Western Pacific (C, F) for data visualisation purposes. For the interpretation of the equity index, a negative index indicated that deworming was 
concentrated in wealthier households on average, whereas a positive index indicated that deworming was concentrated in poorer households. Greyed areas of the map are where data are not 
available or soil-transmitted helminths are not endemic. 
A C
E
B
D F
Deworming coverage
Equity index
0% 20% 40% 60% >80%
<–0·4 –0·2 0 0·2 >0·4
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multivariable logistic regression model with a dependent 
variable of mother-reported deworming to compute the 
correlates of deworming.27 The analysis included a 
prespecified set of correlates based on previous literature 
(appendix p 10).7,24 We included country fixed effects, 
which controlled for all time-invariant differences 
between countries (eg, baseline country differences in 
economic status or soil-transmitted helminthiasis dis ease 
burden), although tested subnational region level fixed 
effects in sensitivity analysis. We estimated the marginal 
effects for correlates of deworming among children for 
ease of interpretation, and used robust standard errors 
clustered by country and survey.28 In the sensitivity 
analysis, we repeated the analysis with larger sample size 
with alternative variable selection (appendix p 12).
We computed the ecological correlates of equity in 
deworming using all available survey data averaged at a 
subnational level. We used an ordinary least squares 
regression model with a dependent variable of 
subnational equity index, and independent variables of 
region-level averages of the prespecified set of correlates 
as described above. We estimated the absolute change in 
equity index associated with a unit value for each 
covariate at an ecological region level. For multivariable 
analyses, we repeated the analysis using countries in 
sub-Saharan Africa alone given potential differences 
with deworming programmes. All analyses used 
R software (version 3.2.3, R Foundation for Statistical 
Computing; Vienna, Austria).
Role of the funding source
The corresponding author had full access to all the data 
in the study and takes responsibility for the integrity of 
the data and the accuracy of the data analysis. The 
funding organisations had no role in the design and 
conduct of the study; collection, management, analysis, 
and interpretation of the data; and preparation, review, or 
approval of the manuscript; or the decision to submit the 
manuscript for publication.
Results
The study included household survey data on 
820 883 preschool age children over the period of 
December, 2003, to October, 2017; the most recent 
surveys for each country included data for 628 489 
children (table 1). We included 77 Demographic and 
Health Surveys from 50 countries, including from Africa 
(n=35), the Americas (n=5), South East Asia, Eastern 
Mediterranean, and Western Pacific (n=9), and Europe 
(n=1; panel). The characteristics of our study population 
are shown in table 1.
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Figure 2: Geographical variation in maternal-reported deworming equity by 
country and sex
We estimated an equity index for deworming at a subnational level for each 
study country, which provided data on within country variation of deworming 
equity. The analysis was conducted independently by sex for comparison of 
equity by sex for each study country. The width of each box provides the 
2·5th and 97·5th percentile of the equity index computed for each country. 
For interpretation, the width of each bar corresponds with the magnitude of 
within country variation in equity; in which a negative index indicated 
deworming was concentrated in wealthier households, whereas a positive index 
indicated deworming was concentrated in poorer households. The vertical line 
in each bar represents the mean equity index. 
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Across all countries and years, 33·0% (95% CI 
32·9–33·1) of mothers reported that their child received 
deworming in the past 6 months. Deworming coverage 
varied substantially across countries, with an even higher 
degree of within-country variation (figure 1). Deworming 
coverage in areas that are endemic for soil-transmitted 
helminthiasis varied by country, from 5·1% (Azerbaijan) 
to 73·6% (Rwanda) and varied further at the subnational 
(regional) level, which ranged from 0·5% (Zamfara, 
Nigeria) to 87·5% (Kavango, Namibia). The estimated 
proportion of variation in deworming coverage explained 
by within-country factors (eg, state policies, variation in 
wealth and health-care access within a country, etc) was 
90·8% (95% CI 90·6–90·9), whereas the remaining 
9·2% (9·0–9·4) was attributable to between-country 
factors (eg, national policies and programmes). The 
national deworming coverage reported to WHO was 
greater than the coverage estimated by Demographic and 
Health Survey data in 40 of 45 cases, with a mean 
difference of 36% (range –35 to 75).
In our study population, deworming of preschool 
children increased linearly with household wealth, 
ranging from deworming coverage of 27·5% (95% CI 
27·3–27·7) for children in the lowest wealth quintile to 
38·3% (38·1–38·5) in the highest quintile. Of the 
50 countries, 14 had a negative equity index in every 
endemic region of the country (eg, in Nigeria, we found a 
28% absolute difference in deworming coverage between 
children in the lowest and highest wealth quintile). 
At a subnational level, some countries had substantial 
within-country variation in the equity index, including 
Azerbaijan, Burkina Faso, India, Nigeria, Peru, and 
Philippines. Of the 31 study countries reported to WHO 
to have achieved a national deworming coverage greater 
than the global public health goal of 75% (appendix pp 9), 
we found that 30 had a negative mean equity index. 
We calculated equity index independently by sex, and 
notably did not find substantial systematic differences 
between boys and girls in deworming equity index across 
study countries (figure 2).
Figure 3: Trends in maternal-reported deworming equity over time and by programmatic coverage
(A) We estimated an equity index for deworming in countries with surveys at different time periods, which provided data for country trends for geographical variation 
in deworming equity. The width of each box provides the 2·5th and 97·5th percentile of the equity index computed for each country. The bars are grouped by country, 
with more recent surveys shown on the lower bars. For interpretation, deworming equity was considered to improve for a country with a reduced width of the bar 
(reduced within country variation in equity) or a mean index (vertical line in bars) closer to zero (equal across wealth classes). (B) We fitted the relationship for 
subnational mean deworming coverage and equity index for all study countries. (C) We estimated the discrete annualised change in mean deworming coverage and 
the corresponding annualised change in equity index for study countries with surveys at different time periods. 
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For countries with multiple Demographic and Health 
Surveys, we found modest improvements in deworming 
coverage and equity across wealth classes over time. We 
found an average increase in these countries in national 
deworming coverage by 0·7% annually. For temporal 
trends in the equity index, we estimated that eight countries 
had notable improvements in deworming equity, ten 
countries had no changes, and four countries became less 
equitable (appendix p 8 for definitions). We found a 
qualitative trend at the subnational level that regions with 
higher coverage had a less negative equity index (figure 3). 
When estimated subnational deworming coverage ap-
proached 70% using study coverage estimates, the mean 
equity index approached zero (ie, suggesting equal dis-
tribution of deworming across wealth classes). Similarly, 
when we estimated how subnational changes in mean 
deworming coverage were associated with corresponding 
changes in equity index, we found that higher coverage 
was related to a modestly more positive equity index 
(figure 3).
In a multivariable analysis, we found that medicine for 
deworming during the previous 6 months was most 
strongly associated with vitamin A supplementation 
and DPT3 vaccine, child’s age, and maternal education 
(table 2). We found weaker associations between dewor-
ming and greater family wealth and improved toilets. 
There was a modest relationship between deworming and 
sex (adjusted marginal effects –0·5, 95% CI –0·7 to –0·2), 
which corresponded with a 0·5% lower coverage in girls 
(table 2). In an ecological multivariable analysis, we found 
a positive equity index was most strongly associated with 
high coverage of DTP3 vaccine and vitamin A 
supplementation, average child age, maternal education, 
and wealthier populations at a subnational level (appendix 
p 11). The estimated explanatory value of sex on the 
variation in deworming equity was less than 1%. When 
examining sub-Saharan African countries alone, we found 
these relationships to be generally consistent with some 
differences for ecological correlates of equity (appendix 
pp 13, 14). The results were generally robust to alternative 
variable selection to reduce missing data and alternative 
statistical specifications (appendix pp 12, 15).
Discussion
In this empirical study, we used cross-sectional house-
hold survey data on maternal-reported deworming 
in 820 883 preschool age children in 50 countries to 
estimate the global status and trends in coverage and 
equity for deworming programmes. Although deworming 
is intended to further the goal of health equity, in most 
countries, deworming coverage is highly geographically 
variable and deworming coverage was consistently higher 
in wealthier populations. We do not find systematic 
evidence of sex-related differences in the equity index. 
Of the 31 study countries that reported a greater than 
75% national coverage to WHO, 30 had a negative equity 
index for deworming (greater coverage among wealthier 
populations). Current coverage metrics that report mean 
national coverage would not detect this inequity. Over 
time, deworming coverage by wealth seems to be 
modestly improving to become equal across wealth 
classes, along with associated reductions of within-
country variation in equity. The strongest correlates of 
deworming, as well as a positive equity index, were 
vitamin A supplementation and DTP3 vaccine, which are 
markers of health-care access that might attenuate the 
effects of poverty. The findings from our global empirical 
analysis of cross-sectional household surveys support the 
need for mea surement of equity in national deworming 
programmes and shows the potential to incorporate 
secondary data sources into the measurement framework.
The goal of equity lies at the foundation of global health, 
despite the challenge of achieving it.29 Measurement of 
equity has become increasingly considered in the 
evaluation of global health programmes. Goal 10 of the 
Sustainable Development Goals set in 2015 is to reduce 
inequities, and WHO now includes equity as a core 
consideration in their evaluation of evidence and 
guidelines.18 Analyses of global health programmes have 
addressed equity, for example in the case of 
DTP3 vaccination where data showed persistent, but 
decreasing, inequity.30 An equity index for multiple 
neglected tropical diseases of national programmes has 
also been developed.31 However, most of these analyses 
have examined trends at the national rather than 
subnational level. They have not disaggregated by wealth 
and sex, which limits interpretation and development 
of an equity metric that can be incorporated into 
programmatic use.
Deworming is often stated to be so-called pro-poor 
given that soil-transmitted helminthiasis and other 
neglected tropical diseases most commonly affect the 
Adjusted 
marginal effects
95% CI
Age (year) 6·3 4·0 to 8·6*
Female sex –0·5 –0·7 to –0·2*
Wealth quintile 1·2 0·6 to 1·7*
Children with mother’s age of more 
than 30 years
–0·8 –1·3 to –0·4*
Rural residence 0·6 –0·2 to 1·5
Mother’s education (tertile)† 3·3 2·5 to 4·0*
Improved drinking water source 0·6 –0·4 to 1·6
Improved sanitation facility or toilet 1·4 0·5 to 2·2*
3rd dose of DTP vaccine 10·0 7·5 to 12·6*
Vitamin A 33·1 30·6 to 35·6*
Marginal effects refer to absolute change in mean deworming coverage associated 
with one unit change in variable. Robust standard errors clustered by country and 
survey. DTP=diphtheria, tetanus, and pertussis. *Indicates a relationship with a 
p<0·05. †Is this the marginal effect obtained by 1 unit change in the mother’s 
education.  
Table 2: Correlates of maternal-reported deworming in preschool age 
children
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poor.2,11,13–16 However, an intervention such as deworming 
would not be pro-poor if, despite high burden among 
poor people, empirical evidence finds coverage is 
concentrated among the wealthy. The empirical evidence 
for this issue was explicitly tested with our analysis. The 
definition of equity in health interventions is complex, 
and in this study, we define equity as deworming 
coverage that is generally proportional to risk of soil-
transmitted helminthiasis. In that context, the numerical 
range for the equity index that represents equitable 
deworming coverage is likely to be modestly positive. 
This value would reflect the modestly (but not extremely) 
higher prevalence and transmission of soil-transmitted 
helmin thiasis in poorer population. We did not find 
strong evidence that deworming is consistently pro-
poor; the deworming equity index was negative in most 
settings, meaning that deworming is more concentrated 
in wealthier populations. In most countries, national 
deworming coverage estimated by maternal-reported 
Demographic and Health Survey data was also sub-
stantially lower than coverage data reported to WHO, 
which might reflect both limitations in obtaining self-
reported deworming status or robustness in national 
reporting of deworming coverage. No clear differences 
were noted in deworming equity by sex. However, this 
finding does not exclude the possibility of sex inequity 
in many settings and supports the need for ongoing 
monitoring of sex equity.32 As deworming coverage 
increased, the equity index trended towards higher 
relative coverage in poorer populations, suggesting 
some progress towards achieving pro-poor coverage 
is feasible.
Historically, the key metric in deworming for defining 
public health goals and monitoring programmatic 
progress has been national coverage. WHO defines the 
public health goal for soil-transmitted helminthiasis as 
achieving greater than 75% national coverage of dewor-
ming in preschool and school-age children. However, 
overall national coverage estimates can appear high while 
substantial inequities persist across geography, wealth, 
and sex (a concept referred to as the tyranny of averages).17 
Many countries have substantial variation in deworming 
equity within the country, which is not captured with 
national coverage alone, while other countries have little 
within-country variation. The large subnational variation 
within some countries might represent subnational 
differences in robustness of programme coverage and 
health-care access, although it might also be influenced 
by size of the country and number of regions that report 
coverage.14,31 As the largest variations in coverage are 
not explained at a national level (eg, country guidelines, 
national policy), this finding might underscore the impor-
tance of reporting subnational coverage data. Notably, 
deworming coverage data is often monitored and reported 
on a subnational level by programme managers and 
Ministries of Health, although these data are not used to 
set current WHO public health goals. This analysis lends 
support to efforts to use subnational data to estimate 
equity of coverage across demographic groups (eg, wealth 
and sex) to guide public health programmes. In practice, 
routine reporting of programmatic coverage can be 
complemented by an equity index based on Demographic 
and Health Surveys data.
We estimated that the strongest household correlates 
of deworming receipt were vitamin A supplementation 
and DTP3 vaccine. The relationship with vitamin A is 
probably related to the common co-administration of 
deworming and vitamin A in preschool children in mass 
community-based campaigns, whereas the relationship 
with DTP3 (ie, completion of all three doses) is more 
a marker of access to general health services (both 
household and systems-level indicator) and access to 
health information given a mother’s education level 
than a causal factor. The strongest ecological predictors 
of a positive deworming equity index shared these 
characteristics and were identified as subnational 
regions with higher coverage of DTP3 and vitamin A 
supplementation. The data suggest that where strong 
health-care services exist, such as routine health care 
(eg, three doses of DTP3) and public health programmes 
(vitamin A provision), deworming equity is likely to be 
greater, although the relationship can be complex.14,29,31,32
The study has several limitations. The main outcome 
variable, deworming during the past 6 months, was 
proxy-reported by the mother and was subject to recall 
bias, which could in theory vary by maternal wealth. 
However, previously published data suggest that the 
reliability of self-reported and mother proxy-report for 
deworming through mass drug administration is rea-
sonably good. These data would support the use of 
mother-reported deworming data from Demographic and 
Health Surveys, although this study33 was from a single 
site and highlighted challenge of when multiple pills 
were given. The proxy-reported deworming variable in 
this study would have included both programmatic 
deworming (eg, preventive chemotherapy, through 
child health days) and unprogrammed deworming 
(eg, treatment from the local pharmacy or health-care 
centre).34,35 However, deworming is commonly given with 
vitamin A supplements during child health days; the fact 
that 82% of children dewormed during the previous 
6 months also were reported to have received vitamin A 
supplements during the same timeframe suggests that 
most deworming occurred in the context of preventive 
chemotherapy. Importantly, wealthier households might 
be more likely to purchase or obtain deworming 
medication in an unprogrammed setting (eg, health 
clinic and pharmacy), which would bias study findings 
towards an inequitable distribution (ie, higher coverage 
in wealthier populations) when measuring equity for 
programmatic deworming. Furthermore, maternal 
reports might misclassify the type or purpose of drugs 
given during child health days, which could underestimate 
deworming (eg, child could receive albendazole for 
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empirical treatment of lymphatic filariasis, and not 
recognise its dual role as a deworming medicine) or over-
estimate deworming (eg, child could receive vitamin A 
supplementation and report this inter vention as 
deworming given common co-administration). The 
nationally representative nature of Demographic 
and Health Surveys data and predetermined sample size 
limit the granularity of subnational analyses, thus the 
geographical regions in this study are often larger than 
the unit of programmatic decision making. There are 
alternative mathematical formulations for the equity 
index that can affect this estimate, therefore relative 
comparison of equity index for trends are more robust 
than use of the absolute value of the index. We excluded 
geographical regions (national and subnational) known 
to be non-endemic for soil-transmitted helminthiasis or 
to have sufficiently low prevalence so that preventive 
chemotherapy is not recommended, although up-to-date 
data on soil-transmitted helminthiasis prevalence and 
geographical coverage of national deworming pro-
grammes were not always complete (appendix pp 3,4).
In conclusion, deworming coverage and equity in 
children of preschool age is highly variable, which is not 
evident in national data reported to WHO. Specifically, 
in most countries, deworming does not reach the 
poor equally despite deworming being considered an 
equitable intervention. Demographic and Health Survey 
data can be used to inform the equity of programmatic 
deworming to address the global burden of soil-trans-
mitted helminthiasis.
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